Hemant Surgical Industries Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Hemant Surgical Industries Ltd is ₹ 573.6 as of 30 Oct 15:30 . The P/E Ratio of Hemant Surgical Industries Ltd changed from 12.9 on March 2025 to 15.6 on March 2026 . This represents a CAGR of 9.97% over 2 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Hemant Surgical Industries Ltd changed from ₹ 104.03 crore on March 2025 to ₹ 283.59 crore on March 2026 . This represents a CAGR of 65.11% over 2 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Hemant Surgical Industries Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Hemant Surgical Industries Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Hemant Surgical Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Hemant Surgical Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Hemant Surgical Industries Ltd

Hemant Surgical Industries Limited was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Mumbai.
Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai. Company is in the business of Medical Equipment & Supplies in Mumbai.
Its product basket cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables.
In addition, the Company is providing services for maintenance and in running of 5 dialysis centres. The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Hemant Surgical Industries Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Hemant Surgical Industries Ltd or Transgene Biotek Ltd?

Market cap of Hemant Surgical Industries Ltd is 833 Cr while Market cap of Transgene Biotek Ltd is 17 Cr

What are the key factors driving the stock performance of Hemant Surgical Industries Ltd and Transgene Biotek Ltd?

The stock performance of Hemant Surgical Industries Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hemant Surgical Industries Ltd and Transgene Biotek Ltd?

As of October 31, 2026, the Hemant Surgical Industries Ltd stock price is INR ₹573.6. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.33.

How do dividend payouts of Hemant Surgical Industries Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Hemant Surgical Industries Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.